Similar articles

• [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].

  Hofmann W, Langkopf B. Hofmann W, et al. Z Urol Nephrol. 1982 Dec;75(12):889-95. Z Urol Nephrol. 1982. PMID: 6819737 German. No abstract available.
• [Progress in the internist treatment of bladder tumors].

  Baumgartner G. Baumgartner G. Wien Med Wochenschr. 1982 Jul 31;132(13-14):305-12. Wien Med Wochenschr. 1982. PMID: 6814073 Review. German.
• [Intravesical chemotherapy in superficial tumors of the bladder].

  Schulman CC. Schulman CC. Arch Esp Urol. 1983 Jan-Feb;36(1):32-40. Arch Esp Urol. 1983. PMID: 6409013 Spanish. No abstract available.
• Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.

  Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T. Gohji K, et al. Jpn J Clin Oncol. 1993 Oct;23(5):291-8. Jpn J Clin Oncol. 1993. PMID: 7693990 Clinical Trial.
• [Chemotherapy of bladder tumors].

  Vallet D, Cappelaere P, Adenis L, Demaille A. Vallet D, et al. Lille Med. 1978 Aug-Sep;23(7):486-9. Lille Med. 1978. PMID: 364222 Review. French. No abstract available.